Dr. Brian P. Mieczkowski, D.O.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- New York College of Osteo Medicine of New York Institute of Technology (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 298
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: New York College of Osteo Medicine of New York Institute of Technology
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
MO license 2014007846 -
Internal Medicine Physician
NC license 2009-01056 · OH license 34.009866 -
Student in an Organized Health Care Education/Training Program
CT license 3571 M31
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Centerpoint Medical Center Independence, MO
- Research Medical Center Kansas City, MO
- Lee's Summit Medical Center Lees Summit, MO
- Belton Regional Medical Center Belton, MO
- Cass Regional Medical Center Harrisonville, MO
Medical groups
- Kansas City Pulmonology Practice LLC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 298
- Services billed
- 1,042
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 118 | 55 |
| Critical care, first 30-74 minutes | 76 | 38 |
| Established patient office or other outpatient visit, 30-39 minutes | 73 | 60 |
| New patient office or other outpatient visit, 45-59 minutes | 48 | 48 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 42 | 36 |
| Established patient office or other outpatient visit, 20-29 minutes | 32 | 31 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 30 | 27 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 28 | 28 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 21 | 19 |
| Test to measure expiratory airflow and volume | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Kansas City, MO | 77 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Kansas City, MO | 59 |
| Prednisone Other prescribers in Kansas City, MO | 46 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Kansas City, MO | 45 |
| Omeprazole Other prescribers in Kansas City, MO | 42 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Kansas City, MO | 40 |
| Montelukast Sodium Other prescribers in Kansas City, MO | 40 |
| Azithromycin Other prescribers in Kansas City, MO | 38 |
| Gabapentin Other prescribers in Kansas City, MO | 32 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Kansas City, MO | 31 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 43 payments worth $923 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $177 |
|---|---|
| Genzyme Corporation | $152 |
| Grifols USA, LLC | $80.15 |
| Regeneron Healthcare Solutions, Inc. | $80.02 |
| Jazz Pharmaceuticals Inc. | $63.08 |
| Harmony Biosciences LLC | $61.74 |
| GlaxoSmithKline, LLC. | $56.96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.11 |
| Food and Beverage | $923 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.